Compounds > dihydroergotamine
Page last updated: 2024-08-21

dihydroergotamine and Retroperitoneal Fibrosis

dihydroergotamine has been researched along with Retroperitoneal Fibrosis in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abe, S; Hasegawa, H; Ide, H; Kawakami, Y; Nishimura, M; Oguma, Y1
Ghedira, H; Lacronique, J; Malaquin, F; Ostinelli, J; Urban, T1
Bresque, E; Lagoutte, F; Vérin, P; Vizdy, A1

Other Studies

3 other study(ies) available for dihydroergotamine and Retroperitoneal Fibrosis

ArticleYear
[A case of retroperitoneal fibrosis following dihydroergotamine therapy, with special reference to partial diabetes insipidus and positive Ga scan].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1984, Volume: 73, Issue:6

    Topics: Aged; Diabetes Insipidus; Dihydroergotamine; Gallium Radioisotopes; Humans; Male; Radionuclide Imaging; Retroperitoneal Fibrosis

1984
Pleural and retroperitoneal fibrosis from dihydroergotamine.
    The New England journal of medicine, 1989, Dec-21, Volume: 321, Issue:25

    Topics: Dihydroergotamine; Female; Fibrosis; Humans; Middle Aged; Pleural Diseases; Retroperitoneal Fibrosis

1989
[Retroperitoneal fibrosis and ergot derivatives. Ophthalmological adverse effects].
    Bulletin des societes d'ophtalmologie de France, 1974, Volume: 74, Issue:3

    Topics: Dihydroergotamine; Ergotamines; Humans; Male; Middle Aged; Migraine Disorders; Retroperitoneal Fibrosis

1974